Search Results - "Cobo‐Vuilleumier, Nadia"
-
1
Thyroid hormones in diabetes, cancer, and aging
Published in Aging cell (01-11-2020)“…Thyroid hormones are central in the control of health and disease. Here we review the latest findings in thyroid hormone research in the field of diabetes,…”
Get full text
Journal Article -
2
Molecular Modelling of Islet β-Cell Adaptation to Inflammation in Pregnancy and Gestational Diabetes Mellitus
Published in International journal of molecular sciences (06-12-2019)“…Gestational diabetes mellitus (GDM), a metabolic disease that develops with the increase in insulin resistance during late pregnancy, is currently one of the…”
Get full text
Journal Article -
3
Harnessing the Endogenous Plasticity of Pancreatic Islets: A Feasible Regenerative Medicine Therapy for Diabetes?
Published in International journal of molecular sciences (19-04-2021)“…Diabetes is a chronic metabolic disease caused by an absolute or relative deficiency in functional pancreatic β-cells that leads to defective control of blood…”
Get full text
Journal Article -
4
Roles of extracellular vesicles associated non-coding RNAs in Diabetes Mellitus
Published in Frontiers in endocrinology (Lausanne) (22-12-2022)“…Extracellular vesicles (EVs), especially exosomes (50 to 150 nm), have been shown to play important roles in a wide range of physiological and pathological…”
Get full text
Journal Article -
5
LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus
Published in Nature communications (16-04-2018)“…Type 1 diabetes mellitus (T1DM) is due to the selective destruction of islet beta cells by immune cells. Current therapies focused on repressing the immune…”
Get full text
Journal Article -
6
Levothyroxine enhances glucose clearance and blunts the onset of experimental type 1 diabetes mellitus in mice
Published in British journal of pharmacology (01-11-2017)“…Background and Purpose Thyroid hormones induce several changes in whole body metabolism that are known to improve metabolic homeostasis. However, adverse side…”
Get full text
Journal Article -
7
Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage
Published in Biomedicine & pharmacotherapy (01-01-2022)“…The atypical cannabinoid Abn-CBD improves the inflammatory status in preclinical models of several pathologies, including autoimmune diseases. However, its…”
Get full text
Journal Article -
8
The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease
Published in Frontiers in endocrinology (Lausanne) (06-03-2020)“…The synthetic atypical cannabinoid Abn-CBD, a cannabidiol (CBD) derivative, has been recently shown to modulate the immune system in different organs, but its…”
Get full text
Journal Article -
9
The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice
Published in Scientific reports (21-06-2017)“…LH-21 is a triazol derivative that has been described as a low-permeant neutral CB1 antagonist, though its pharmacology is still unclear. It has been…”
Get full text
Journal Article -
10
Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors
Published in Histochemistry and cell biology (01-11-2011)“…The paired box transcription factor Pax8 is critical for development of the eye, thyroid gland as well as the urinary and reproductive organs. In adult, Pax8…”
Get full text
Journal Article -
11
NR5A2/LRH-1 regulates the PTGS2-PGE2-PTGER1 pathway contributing to pancreatic islet survival and function
Published in iScience (20-05-2022)“…LRH-1/NR5A2 is implicated in islet morphogenesis postnatally, and its activation using the agonist BL001 protects islets against apoptosis, reverting…”
Get full text
Journal Article -
12
Targeting LRH-1/NR5A2 to treat type 1 diabetes mellitus
Published in Cell Stress (22-05-2018)“…Type 1 diabetes mellitus (T1DM) is defined as an autoimmune disease that targets the selective destruction of islet insulin-producing beta cells by…”
Get full text
Journal Article -
13
Dissecting the Brain/Islet Axis in Metabesity
Published in Genes (08-05-2019)“…The high prevalence of type 2 diabetes mellitus (T2DM), together with the fact that current treatments are only palliative and do not avoid major secondary…”
Get full text
Journal Article -
14
Clinical Heterogeneity in Monogenic Diabetes Caused by Mutations in the Glucokinase Gene (GCK-MODY)
Published in Diabetes care (01-02-2010)“…OBJECTIVE: To evaluate the heterogeneity in the clinical expression in a family with glucokinase mature-onset diabetes of the young (GCK-MODY). RESEARCH DESIGN…”
Get full text
Journal Article -
15
Corrigendum to “Islet β-Cell Mass Preservation and Regeneration in Diabetes Mellitus: Four Factors with Potential Therapeutic Interest”
Published in Journal of transplantation (2019)“…In the article titled “Islet β-Cell Mass Preservation and Regeneration in Diabetes Mellitus: Four Factors with Potential Therapeutic Interest” [1], a grant…”
Get full text
Journal Article -
16
A Simple High Efficiency Intra-Islet Transduction Protocol Using Lentiviral Vectors
Published in Current gene therapy (01-01-2015)“…Successful normalization of blood glucose in patients transplanted with pancreatic islets isolated from cadaveric donors established the proof-of-concept that…”
Get more information
Journal Article -
17
Time for a paradigm shift in treating type 1 diabetes mellitus: coupling inflammation to islet regeneration
Published in Metabolism, clinical and experimental (01-03-2020)“…Type 1 diabetes mellitus (T1DM) is an autoimmune disease that targets the destruction of islet beta-cells resulting in insulin deficiency, hyperglycemia and…”
Get full text
Journal Article -
18
Islet β-Cell Mass Preservation and Regeneration in Diabetes Mellitus: Four Factors with Potential Therapeutic Interest
Published in Journal of Transplantation (01-01-2012)“…Islet β-cell replacement and regeneration are two promising approaches for the treatment of Type 1 Diabetes Mellitus. Indeed, the success of islet…”
Get full text
Journal Article -
19
The PTGS2/COX2-PGE2 signaling cascade in inflammation: Pro or anti? A case study with type 1 diabetes mellitus
Published in International journal of biological sciences (01-01-2023)“…Prostaglandins are lipid mediators involved in physiological processes, such as constriction or dilation of blood vessels, but also pathophysiological…”
Get full text
Journal Article -
20